Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Vaccine|December 28, 2010
Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patientsCécile L Tremblay, Danielle Rouleau, Claude Fortin, et al.Heliyon|June 3, 2024
Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, CanadaHenintsoa Rabezanahary, Caroline Gilbert, Kim Santerre, et al.Vaccine|May 31, 2008
Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platformJérôme Denis, Elizabeth Acosta-Ramirez, Yinghi Zhao, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2010
Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infectionsJesse Papenburg, Mariana Baz, Marie-Ève Hamelin, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.Memorias Do Instituto Oswaldo Cruz|January 18, 2023
Detection and genome characterisation of SARS-CoV-2 P.6 lineage in dogs and cats living with Uruguayan COVID-19 patientsYanina Panzera, Santiago Mirazo, Mariana Baz, et al.Frontiers in Immunology|January 29, 2025
Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory responseHend Jarras, Isalie Blais, Benjamin Goyer, et al.Plos One|December 16, 2024
Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasetsAbdelhadi Djaïleb, Megan-Faye Parker, Étienne Lavallée, et al.Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.IJID Regions|June 27, 2025
Clinical presentation of Enterovirus D68 in adults with acute respiratory infections consulting in emergency departments in Quebec, CanadaMaria Christina Mallet, Sylvie Trottier, Mariana Baz, et al.Pageof 7